Clinical neuro-oncology for the neurologist
- PMID: 33299675
- PMCID: PMC7717629
- DOI: 10.1212/CPJ.0000000000000765
Clinical neuro-oncology for the neurologist
Abstract
Purpose of review: Neuro-oncologic patients are routinely encountered in clinical practice. Neuro-oncology is a rapidly evolving field, so understanding the most classic paradigms and contemporary advances will optimize patient care.
Recent findings: We discuss the recent reclassification of tumors via molecular characteristics as it applies to direct clinical practice and review the contemporary standard of care for infiltrating gliomas, meningiomas, brain metastases, and CNS lymphoma.
Summary: We provide a straightforward primer on neuro-oncology with a focus on the brain tumors most commonly encountered by the adult neurologist and a clear emphasis on clinically relevant points including those which have recently become incorporated into our standard management. We cite key reviews to allow interested readers an opportunity to gain a more comprehensive understanding of specific topics.
© 2019 American Academy of Neurology.
Figures


References
-
- Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 2004;22:2865–2872. - PubMed
-
- Fidler IJ, Yano S, Zhang RD, Fujimaki T, Bucana CD. The seed and soil hypothesis: vascularization and brain metastases. Lancet Oncol 2002;3:53–57. - PubMed
-
- Fidler IJ. The biology of brain metastasis: challenges for therapy. Cancer J 2015;21:284–293. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials